Dr Reddy's Laboratories Ltd has signed a licensing agreement with US-based Ingenus Pharmaceuticals to commercialize Cyclophosphamide injection for cancer treatment. Dr Reddy's USA will commercialize the injection in the US market, paying Ingenus 50% of the calculated profit share.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/w6SFzTY
via IFTTT
No comments:
Post a Comment